Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 144 checked references that resolve
resolves10.1159/000313946Renal Interstitial Fibrosis: A Critical Evaluation of the Origin of Myofibroblasts
resolves10.1093/ndt/gfl691PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis
resolves10.1038/nm.3218Origin and function of myofibroblasts in kidney fibrosis
resolves10.1086/597350Assessment of Liver Fibrosis by Transient Elastography in Persons with Hepatitis C Virus Infection or HIV–Hepatitis C Virus Coinfection
resolves10.1097/RLI.0b013e31827a4990Magnetic Resonance Elastography Noninvasively Detects In Vivo Renal Medullary Fibrosis Secondary to Swine Renal Artery Stenosis
resolves10.2215/CJN.02560706Can We Rely on Blood Urea Nitrogen as a Biomarker to Determine When to Initiate Dialysis?
resolves10.1038/ki.1995.40Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine
resolves10.1093/glycob/7.4.499Molecular characterization of β-trace protein in human serum and urine: a potential diagnostic marker for renal diseases
resolves10.1681/ASN.2005010076Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease
resolves10.1159/000336109Elevated Plasma Levels of Endostatin Are Associated with Chronic Kidney Disease
resolves10.1056/NEJMoa0706130Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
resolves10.1681/ASN.2010121224FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
resolves10.1001/jama.2011.826Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
resolves10.1159/000104428Messenger RNA Expression of Podocyte-Associated Molecules in the Urinary Sediment of Patients with Diabetic Nephropathy
resolves10.1159/000074322Urinary Sediment Podocalyxin in Children with Glomerular Diseases
resolves10.2215/CJN.03530708Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
resolves10.1002/jcp.24267Kidney injury molecule‐1: More than just an injury marker of tubular epithelial cells?
resolves10.1002/path.2175Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
resolves10.1053/j.ajkd.2009.11.009Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)
resolves10.1016/S0009-8981(00)00237-0Diagnostic value of urinary alanine aminopeptidase and N-acetyl-β-d-glucosaminidase in comparison to α1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients
resolves10.1016/j.lab.2003.08.001Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease
resolves10.2337/dc09-2242Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
resolves10.1016/j.transproceed.2008.10.088Neutrophil Gelatinase-Associated Lipocalin Is a New and Sensitive Marker of Kidney Function in Chronic Kidney Disease Patients and Renal Allograft Recipients
resolves10.1053/j.ajkd.2012.05.014Associations of Urinary Levels of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) With Kidney Function Decline in the Multi-Ethnic Study of Atherosclerosis (MESA)
resolves10.1002/path.1437Functional structure and composition of the extracellular matrix
resolves10.1681/ASN.2005121298A Hypomorphic Mutation in the Mouse Laminin α5 Gene Causes Polycystic Kidney Disease
resolves10.2353/ajpath.2010.090570Laminin α4-Null Mutant Mice Develop Chronic Kidney Disease with Persistent Overexpression of Platelet-Derived Growth Factor
resolves10.1093/ndt/15.12.1956Abnormal expression of glomerular basement membrane laminins in membranous glomerulonephritis
resolves10.1016/j.metabol.2009.05.025Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats
resolves10.2337/dc10-0199Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
resolves10.1681/ASN.2008121233Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
resolves10.1093/ndt/gfn758Glomerular filtration is normal in the absence of both agrin and perlecan–heparan sulfate from the glomerular basement membrane
resolves10.1038/sj.ki.5002706Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria
resolves10.2353/ajpath.2007.061116Disruption of Glomerular Basement Membrane Charge through Podocyte-Specific Mutation of Agrin Does Not Alter Glomerular Permselectivity
resolves10.1046/j.1523-1755.2000.00317.xSmall proteoglycans of normal adult human kidney: Distinct expression patterns of decorin, biglycan, fibromodulin, and lumican
resolves10.1053/meta.2001.28074Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice
resolves10.1002/jcla.10099Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy
resolves10.1159/000058345Matrix Metalloproteinases and Their Inhibitions in Experimental Renal Scarring
resolves10.1038/labinvest.2013.42Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy
resolves10.1002/jemt.20565Human matrix metalloproteinases: Characteristics and pathologic role in altering mesangial homeostasis
resolves10.1097/01.TP.0000066809.60389.48Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients
resolves10.1172/JCI114731Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
resolves10.1038/360361a0Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
resolves10.1016/j.coph.2009.11.007Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases
resolves10.1038/nm.2989Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis
resolves10.1038/nm0496-418Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
resolves10.1177/44.4.8601689Distribution of the large aggregating proteoglycan versican in adult human tissues.
resolves10.1111/j.1440-1827.2010.02547.xMatrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases
resolves10.1093/ndt/gfr583ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis
resolves10.1038/sj.ki.5001753ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deterioration
resolves10.1016/j.etp.2007.01.003Expression and significance of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 in an animal model of renal interstitial fibrosis induced by unilateral ureteral obstruction
resolves10.1159/000339645Urinary Matrix Metalloproteinase Activity in Diabetic Kidney Disease: A Potential Marker of Disease Progression
resolves10.2353/ajpath.2006.050896Role for Macrophage Metalloelastase in Glomerular Basement Membrane Damage Associated with Alport Syndrome
resolves10.1074/jbc.271.25.15074Matrix Metalloproteinase 2 (Gelatinase A) Regulates Glomerular Mesangial Cell Proliferation and Differentiation
resolves10.1159/000028023Changes in Matrix Metalloproteinases during the Evolution of Interstitial Renal Fibrosis in a Rat Experimental Model
resolves10.1038/ki.1996.10Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat
resolves10.1002/jcla.20024Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy
resolves10.3109/1354750X.2013.789084Quantification of “end products” of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways – implications for modern clinical chemistry
resolves10.1089/adt.2012.474Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue Diseases
<i>Possibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure</i>
resolves10.1016/j.clinbiochem.2011.01.001Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM—Increased serum CIIM in subjects with severe radiographic osteoarthritis
resolves10.1111/liv.12044Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis—a serological evaluation
resolves10.4137/BMI.S9415Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
resolves10.1111/apt.12484Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
resolves10.1186/1471-2466-12-34Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation
resolves10.1186/1471-5945-11-6Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis
resolves10.4137/BMI.S6347Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis
resolves10.1371/journal.pone.0024753MMP Mediated Degradation of Type VI Collagen Is Highly Associated with Liver Fibrosis – Identification and Validation of a Novel Biochemical Marker Assay
resolves10.1186/1755-1536-4-22Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis
resolves10.1186/1755-1536-6-9Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
resolves10.1111/j.1478-3231.2010.02309.xMatrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis
resolves10.3389/fphys.2013.00195Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
resolves10.1111/j.1872-034X.2011.00946.xEnzyme‐linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis
resolves10.1096/fj.06-5898fjeMatrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
resolves10.1159/000147926Altered Kidney Matrix Gene Expression in Early Stages of Experimental Diabetes
resolves10.1152/ajpregu.00300.2005Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
resolves10.1038/ki.1996.421Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia
resolves10.1681/ASN.V591675Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis.
resolves10.1038/ki.2011.254The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
resolves10.1074/jbc.M102859200Global Gene Expression Analysis Reveals a Role for the α1 Integrin in Renal Pathogenesis
resolves10.1016/S0002-9440(10)64937-1Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction
resolves10.2337/db06-0477Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
The 10 references without a DOI — listed, not checked
no DOI — not checkedU.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2013, Bethesda, MD
no DOI — not checkedGoldsmith D, Jayawardene S, Ackland P: ABC of Kidney Disease. 2013, Chichester: John Wiley & Sons, Ltd, 2
no DOI — not checkedO’Callaghan C: The Renal System at a Glance. 2009, Chichester: John Wiley & Sons, Ltd, 3
no DOI — not checkedOkonogi H, Nishimura M, Utsunomiya Y, Hamaguchi K, Tsuchida H, Miura Y, Suzuki S, Kawamura T, Hosoya T, Yamada K: Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol. 2001, 55: 357-364.
no DOI — not checkedVleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol. 1995, 44: 211-219.
no DOI — not checkedBarascuk N, Genovese F, Larsen L, Byrjalsen I, Zheng Q, Sun S, Hosbond S, Poulsen TS, Diederichsen A, Jensen JM, Mickley H, Register TC, Rasmussen LM, Leeming DJ, Christiansen C, Karsdal MA: A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease. Int J Clin Exp Med. 2013, 6: 174-184.
no DOI — not checkedSharma AK, Mauer SM, Kim Y, Michael AF: Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. J Lab Clin Med. 1995, 125: 754-761.
no DOI — not checkedBasile DP, Martin DR, Hammerman MR: Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair. Am J Physiol. 1998, 275: F894-F903.
no DOI — not checkedEddy AA: Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int Suppl. 1996, 54: S49-S54.
no DOI — not checkedRugheimer L, Carlsson C, Johnsson C, Hansell P: Renal hyaluronan content during experimental uncontrolled diabetes in rats. J Physiol Pharmacol. 2008, 59: 115-128.
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.